Physician profile

Sean Caskey

Orthopaedic Surgery · Wenatchee, WA

NPI 1063861102

$16,831.05

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$200.90
Education$187.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $15,030.95 2021-2024 Pico 7
Zimmer Biomet Holdings, INC. $615.41 2019-2023 Persona, Rosa
Medwest Associates $506.42 2019
Stryker Corporation $307.19 2020-2021
Depuy Synthes Sales INC. $135.40 2019-2020
Baxter Healthcare $93.95 2020-2021
Kci USA, INC. $61.76 2019
Surgalign Spine Technologies, INC. $57.81 2019
Acumed LLC $22.16 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sean Caskey

$16,831.05

in general payments reported 2019-2025

Years
2019-2024
Top company
Smith+Nephew, INC.

https://glasscript.com/doctor/2023987/sean-caskey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.